Parsifal Capital Management, LP

In its 13F for Q2 2025 (holdings as of June 30, 2025, filed August 14, 2025), Parsifal Capital Management, LP reported 13 stock positions worth $1.0 billion. Its top holding was Albertsons Cos Class A (ACI) at 14.5% of the portfolio, followed by Dollar Tree (DLTR, 12.8%) and 3M (MMM, 10.3%). Compared with Q1 2025, it opened 1 new position, sold out of 3, added to 8 and reduced 4. The biggest buy was Dollar Tree (DLTR, shares +139%) and the biggest sale Albertsons Cos Class A (ACI, shares −12%).

Most Recent 13F
Q2 2026
Location
GREENWICH, CT
CIK
0001776090
Portfolio Value
$1.0B (Q2 2025)
SEC Filing
0001776090-25-000005 ↗ filed Aug 14, 2025

Holdings Value

0$500.0M$1.0B$1.5B Q1 2024: $1.4B Q1 2024 Q2 2024: $1.4B Q2 2024 Q3 2024: $1.3B Q3 2024 Q4 2024: $1.2B Q4 2024 Q1 2025: $956.2M Q1 2025 Q2 2025: $1.0B $1.0B Q2 2025 Q3 2025: $1.1B Q3 2025 Q4 2025: $992.6M Q4 2025 Q1 2026: $774.6M Q1 2026 Q2 2026: $816.5M Q2 2026

Holdings 13 stocks · $1.0B

ACI Albertsons Cos Inc. Class A 14.52% 7,081,341 $152.3M Reduce -11.8%
DLTR Dollar Tree Inc. 12.80% 1,356,269 $134.3M Add +138.8%
MMM 3M Co. 10.33% 712,152 $108.4M Add +10.5%
SN Sharkninja Inc. 10.01% 1,061,300 $105.1M Add +1.2%
HGV Hilton Grand Vacations Inc. 9.86% 2,491,420 $103.5M Reduce -3.3%
AVPT Avepoint Inc. 9.73% 5,287,356 $102.1M Add +4.1%
ATMU Atmus Filtration Technologie 6.04% 1,739,635 $63.4M Add +4.2%
UNH Unitedhealth Group Inc. 5.50% 185,091 $57.7M Add +82.4%
NTNX Nutanix Inc. Class A 5.44% 746,792 $57.1M Add +10.1%
GMED Globus Medical Inc. Class A 4.80% 852,761 $50.3M Add +14.3%
TEVA Teva Pharmaceutical-SP ADR 4.63% 2,900,630 $48.6M Reduce -31.0%
GXO Gxo Logistics Inc. 3.88% 835,500 $40.7M New
CORZ Core Scientific Inc. 2.46% 1,514,600 $25.9M Reduce -68.5%

Options reported separately and not counted above: SN puts ($105.1M), CORZ puts ($25.9M).

Portfolio Sells Q1 2025 → Q2 2025

ACI Albertsons Cos Inc. Class A Reduce -11.8% 14.52% −3.95
WDC Western Digital Corp. Sold out 0.00% −3.80
CVS CVS Health Corp. Sold out 0.00% −3.01
TEVA Teva Pharmaceutical-SP ADR Reduce -31.0% 4.63% −2.12
CORZ Core Scientific Inc. Reduce -68.5% 2.46% −1.18
BRSL Brightstar Lottery PLC Sold out 0.00% −0.43
HGV Hilton Grand Vacations Inc. Reduce -3.3% 9.86% −0.22

Portfolio Buys Q1 2025 → Q2 2025

DLTR Dollar Tree Inc. Add +138.8% 12.80% +8.34
GXO Gxo Logistics Inc. New 3.88% +3.88
AVPT Avepoint Inc. Add +4.1% 9.73% +2.06
SN Sharkninja Inc. Add +1.2% 10.01% +0.86
NTNX Nutanix Inc. Class A Add +10.1% 5.44% +0.49
MMM 3M Co. Add +10.5% 10.33% +0.43
UNH Unitedhealth Group Inc. Add +82.4% 5.50% −0.06
ATMU Atmus Filtration Technologie Add +4.2% 6.04% −0.37
GMED Globus Medical Inc. Class A Add +14.3% 4.80% −0.91

Options Activity Q1 2025 → Q2 2025

SN Sharkninja Inc. put Add +1.2% 1,061,300 $105.1M
UNH Unitedhealth Group Inc. put Sold out 101,500 $53.2Mbefore exit
CVS CVS Health Corp. put Sold out 425,100 $28.8Mbefore exit
CORZ Core Scientific Inc. put New 1,514,600 $25.9M
HUM Humana Inc. call Sold out 69,500 $18.4Mbefore exit
SWTX Springworks Therapeutics Inc. call Sold out 160,000 $7.1Mbefore exit
DNB Dun & Bradstreet Holdings Inc. call Sold out 589,200 $5.3Mbefore exit

Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 14$816.5MCOMP, HGV, SN, AXTA, AKAM
Q1 2026 17$774.6MCOMP, HGV, SN, AKAM, AXTA
Q4 2025 15$992.6MSN, HGV, GMED, TEVA, GXO
Q3 2025 16$1.1BAVPT, ACI, SN, DLTR, HGV
Q2 2025 13$1.0BACI, DLTR, MMM, SN, HGV
Q1 2025 15$956.2MACI, HGV, MMM, SN, AVPT
Q4 2024 16$1.2BACI, HGV, SN, MMM, CLX
Q3 2024 14$1.3BACI, SN, HGV, CLX, TEVA
Q2 2024 18$1.4BSN, HGV, ACI, CLX, TEVA
Q1 2024 19$1.4BSN, HGV, ACI, CLX, BRSL